145 related articles for article (PubMed ID: 22230688)
1. A new D₂ dopamine receptor agonist allosterically modulates A(2A) adenosine receptor signalling by interacting with the A(2A)/D₂ receptor heteromer.
Trincavelli ML; Daniele S; Orlandini E; Navarro G; Casadó V; Giacomelli C; Nencetti S; Nuti E; Macchia M; Huebner H; Gmeiner P; Rossello A; Lluís C; Martini C
Cell Signal; 2012 Apr; 24(4):951-60. PubMed ID: 22230688
[TBL] [Abstract][Full Text] [Related]
2. Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer.
Marcellino D; Navarro G; Sahlholm K; Nilsson J; Agnati LF; Canela EI; Lluís C; Århem P; Franco R; Fuxe K
Biochem Biophys Res Commun; 2010 Apr; 394(4):988-92. PubMed ID: 20307491
[TBL] [Abstract][Full Text] [Related]
3. Production of functional recombinant G-protein coupled receptors for heteromerization studies.
Cavić M; Lluís C; Moreno E; Bakešová J; Canela EI; Navarro G
J Neurosci Methods; 2011 Aug; 199(2):258-64. PubMed ID: 21658412
[TBL] [Abstract][Full Text] [Related]
4. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes.
Torvinen M; Marcellino D; Canals M; Agnati LF; Lluis C; Franco R; Fuxe K
Mol Pharmacol; 2005 Feb; 67(2):400-7. PubMed ID: 15539641
[TBL] [Abstract][Full Text] [Related]
6. A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R.
Borroto-Escuela DO; Marcellino D; Narvaez M; Flajolet M; Heintz N; Agnati L; Ciruela F; Fuxe K
Biochem Biophys Res Commun; 2010 Mar; 394(1):222-7. PubMed ID: 20197060
[TBL] [Abstract][Full Text] [Related]
7. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
8. On the existence of a possible A2A-D2-β-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced β-arrestin2 recruitment.
Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Ciruela F; Agnati LF; Fuxe K
J Mol Biol; 2011 Mar; 406(5):687-99. PubMed ID: 21256133
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
10. Effect of clozapine on the dimerization of serotonin 5-HT(2A) receptor and its genetic variant 5-HT(2A)H425Y with dopamine D(2) receptor.
Łukasiewicz S; Faron-Górecka A; Kędracka-Krok S; Dziedzicka-Wasylewska M
Eur J Pharmacol; 2011 Jun; 659(2-3):114-23. PubMed ID: 21496455
[TBL] [Abstract][Full Text] [Related]
11. New N-n-propyl-substituted 3-aryl- and 3-cyclohexylpiperidines as partial agonists at the D4 dopamine receptor.
Macchia M; Cervetto L; Demontis GC; Longoni B; Minutolo F; Orlandini E; Ortore G; Papi C; Sbrana A; Macchia B
J Med Chem; 2003 Jan; 46(1):161-8. PubMed ID: 12502370
[TBL] [Abstract][Full Text] [Related]
12. Insilico study of the A(2A)R-D (2)R kinetics and interfacial contact surface for heteromerization.
Prakash A; Luthra PM
Amino Acids; 2012 Oct; 43(4):1451-64. PubMed ID: 22278740
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
14. Development of a bivalent dopamine D₂ receptor agonist.
Kühhorn J; Götz A; Hübner H; Thompson D; Whistler J; Gmeiner P
J Med Chem; 2011 Nov; 54(22):7911-9. PubMed ID: 21999579
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers.
Borroto-Escuela DO; Ravani A; Tarakanov AO; Brito I; Narvaez M; Romero-Fernandez W; Corrales F; Agnati LF; Tanganelli S; Ferraro L; Fuxe K
Biochem Biophys Res Commun; 2013 May; 435(1):140-6. PubMed ID: 23624386
[TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent oligomerization of dopamine D(2) and adenosine A(2A) receptors in living neuronal cells.
Vidi PA; Chemel BR; Hu CD; Watts VJ
Mol Pharmacol; 2008 Sep; 74(3):544-51. PubMed ID: 18524886
[TBL] [Abstract][Full Text] [Related]
17. A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease.
Varani K; Vincenzi F; Tosi A; Gessi S; Casetta I; Granieri G; Fazio P; Leung E; MacLennan S; Granieri E; Borea PA
FASEB J; 2010 Feb; 24(2):587-98. PubMed ID: 19776336
[TBL] [Abstract][Full Text] [Related]
18. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
19. Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics.
Kara E; Lin H; Strange PG
J Neurochem; 2010 Mar; 112(6):1442-53. PubMed ID: 20050980
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
